The Principals have made investments in the following medical device companies:

Aksys, Ltd. (ticker: AKSY) | www.aksys.com | has developed an automated personal hemodialysis system for patient-performed hemodialysis in alternative care settings such as the patient's home.


American Medical Systems Holdings, Inc. (ticker: AMMD) | www.visitams.com |acquired from Pfizer Inc., manufactures and markets devices to surgically treat incontinence and impotence.

 

ArKal Medical, Inc.www.arkalmed.com | is developing a continuous blood glucose sensor for diabetes.

 

Asante Medical, Inc. (formerly M2 Group Holdings, Inc.) | www.m2medinc.com | is developing a disposable drug delivery system which will initially be used for the treatment of Type 1 diabetes.

 

 

Ascent Healthcare Solutions (formed by the merger of Alliance Medical Corporation and Vangaurd Medical Concepts) | www.ascenths.com | reprocesses medical devices for re-use by medical facilities.


Atritech, Inc.www.atritech.net |is focused on developing minimally invasive technologies designed for the prevention of atrial fibrillation related stroke.

 

Visit the AxioMed Main Page

AxioMed Spine Corporationwww.axiomed.com  | is developing a next generation, implantable, artificial disc employing state of the art polymer technology.

 

 

Bausch & Lomb, Inc. | www.bausch.com | is a global leader in medical and consumer eye health.

Endocardial Solutions, Inc. (ticker was ECSI; acquired by St. Jude Medical, Inc. ticker: STJ) | www.sjm.com | marketed a minimally invasive diagnostic system for mapping arrhythmias, potentially fatal or life debilitating heart rhythms.


cid:image002.jpg@01C9D78B.B0E89BB0

 

EndoMetabolic Solutions, Inc. is developing a proprietary medical device for the surgical treatment of obesity.

 

Epicor Medical, Inc. (acquired by St. Jude Medical, Inc. ticker: STJ) | www.sjm.com |developed devices for the treatment of atrial fibrillation.

 

Galil Medical Ltd. | www.galil-medical.com | is a market leader in cryotherapy systems to treat cancerous and benign conditions.

Image-Guided Neurologics, Inc. (acquired by Medtronic, Inc. ticker MDT) | www.medtronic.com | developed and marketed devices to improve the accuracy of, and reduce the time required for, image-guided neurosurgery.

 

Intuity Medical, Inc. | www.intuitymedical.com | is developing an improved glucose monitoring system for diabetes.

 

Leptos BioMedical, Inc. | www.leptosbiomedical.com | is developing a proprietary neuromodulation therapy for chronic obesity.

OsteoBiologics, Inc. (acquired by Smith & Nephew plc  ticker: SNN)  | global.smith-nephew.com/us |developed and marketed bioabsorbable, polymer scaffolds for the treatment of articular cartilage and bone defects.

 

Softscope Medical Technologies, Inc. | www.softscopemed.com | is developing an innovative medical technology designed to facilitate the performance of endoscopic procedures.

 

Torax Medical, Inc. | www.toraxmedical.com | is developing an implantable device to strengthen the esophageal sphincter for the treatment of gastro-esophageal reflux disease (GERD).

Wright Medical Group, Inc. (ticker: WMGI) | www.wmt.com | manufactures and markets a full line of orthopedic implants with leading shares of the small joint replacement and biologically active bone void filler markets.
Xomed Surgical Products, Inc. (ticker was XOMD; acquired by Medtronic, Inc. ticker: MDT) | www.medtronic.com |was acquired from Bristol-Myers Squibb Company, and manufactured and marketed products for the treatment of ear, nose and throat diseases.


« back to top

    © 2010 Thomas, McNerney & Partners - All Rights Reserved.